Table 2.
Descriptive statistics of biomarkers for the study participants (N = 350)
| Variable | Mean (SD) | Variables | Mean (SD) |
|---|---|---|---|
| Hormones | Neurokines | ||
| ACTH, pg/mL | 8.3 (21.0) | ApoE4, pg/mL | 172,025.4 (399,525.6) |
| AGRP, pg/mL | 20.7 (43.4) | ferritin, pg/mL | 344,590.1 (153,675.9) |
| C.Peptide, pg/mL | 740.8 (335.7) | neurogranin, pg/mL | 105.7 (125.3) |
| Cortisol, ng/mL | 49 (16.3) | PRNP, pg/mL | 29,767.4 (29,393.3) |
| GIP, pg/mL | 36.9 (21.5) | cardiovascular biomarkers | |
| Leptin, pg/mL | 4,018.7 (3,742.8) | AGP, ng/mL | 1,456.2 (538.9) |
| T3, ng/mL | 1.5 (1.0) | CRP, ng/mL | 8.5 (17.6) |
| T4, ng/mL | 45.4 (13) | Fetuin-A, ng/mL | 203.5 (55.6) |
| TSH, uiu/mL | 5.0 (4.3) | haptoglobin, ng/mL | 1,112.8 (1,096.3) |
| Inflammations | SAP, ng/mL | 7.6 (3.2) | |
| IL.10, pg/mL | 8.5 (46.2) | cardiovascular functional factors | |
| IL.23, pg/mL | 307 (756.2) | FBG, mmol/L | 6.5 (1.5) |
| IL.4, pg/mL | 218.3 (165.5) | TCHOL, mmol/L | 5.8 (1.3) |
| IL.13, pg/mL | 3.9 (3.4) | TG, mmol/L | 1.6 (0.5) |
| MIP.3.alpha, pg/mL | 15.9 (55.5) | ||
| TNF.alpha, pg/mL | 3.7 (1.4) | ||